Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse

Transplantation

Volumn 87, Issue 1, 2009, Pages 8-15

  Zhong, Maohua ^a   Weng, Xiufang ^a   Liang, Zhihui ^a   Lu, Shengjun ^a   Li, Jianan ^a,b   Chen, Xueling ^a   Li, Qing ^a   Sun, Wei ^a   Song, Yinhong ^a   Shen, Guanxin ^a   Wu, Xiongwen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

Author keywords

ILT2; SHLA G dimer; T cell alloresponse

Indexed keywords

GLYCOPROTEIN; HLA G ANTIGEN; IG LIKE TRANSCRIPT 2; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN;

ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; AUTOIMMUNITY; CELL LINE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; METABOLISM; PROTEIN MULTIMERIZATION; SOLUBILITY; T LYMPHOCYTE;

ANTIGENS, CD; AUTOIMMUNITY; CELL LINE; CELL PROLIFERATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; PROTEIN MULTIMERIZATION; RECEPTORS, IMMUNOLOGIC; SOLUBILITY; T-LYMPHOCYTES; UP-REGULATION;

EID: 58949089431     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818b6141     Document Type: Article

References (50)

1. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994; 153: 5516.
2. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 1992; 89: 3947.
3. Kirszenbaum M, Moreau P, Gluckman E, et al. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 1994; 91: 4209.
4. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220.
5. Moreau P, Carosella E, Teyssier M, et al. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol 1995; 43: 231.
6. Paul P, Cabestre FA, Ibrahim EC, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000; 61: 1138.
7. Creput C, Durrbach A, Menier C, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39: 587.
8. Creput C, Le Friec G, Bahri R, et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients. Hum Immunol 2003; 64: 1033.
9. Le Rond S, Azema C, Krawice-Radanne I, et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immuno-suppressive/ regulatory T cells. J Immunol 2006; 176: 3266.
10. Le Rond S, Le Maoult J, Creput C, et al. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol 2004; 34: 649.
11. Lila N, Amrein C, Guillemain R, et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949.
12. Lila N, Carpentier A, Amrein C, et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
13. Luque J, Torres MI, Aumente MD, et al. Soluble HLA-G in heart transplantation: Their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 2006; 67: 257.
14. Qiu J, Terasaki PI, Miller J, et al. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 2006; 6: 2152.
15. Allan DS, Lepin EJ, Braud VM, et al. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 2002; 268: 43.
16. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lym-phoid and myelomonocytic cells. J Exp Med 1997; 186: 1809.
17. Colonna M, Samaridis J, Cella M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998; 160: 3096.
18. Cosman D, Fanger N, Borges L, et al. A novel immunoglobulin super-family receptor for cellular and viral MHC class I molecules. Immunity 1997; 7: 273.
19. NavarroF, LlanoM, BellonT,et al. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29: 277.
20. Ponte M, Cantoni C, Biassoni R, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96: 5674.
21. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189: 1093.
22. Shiroishi M, Kuroki K, Ose T, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006; 281: 10439.
23. Apps R, Gardner L, Sharkey AM, et al. A homodimeric complex of HLA-Gon normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37: 1924.
24. Boyson JE, Erskine R, Whitman MC, et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002; 99: 16180.
25. Gonen-Gross T, Achdout H, Gazit R, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol 2003; 171: 1343.
26. Gonen-Gross T, Gazit R, Achdout H, et al. Special organization of the HLA-G protein on the cell surface. Hum Immunol 2003; 64: 1011.
27. Shiroishi M, Kohda D, Maenaka K. Preparation and crystallization of the disulfide-linked HLA-G dimer. Biochim Biophys Acta 2006; 1764: 985.
28. Hu HM, Dols A, Meijer SL, et al. Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/ HLA-A2 dimer complexes. J Immunother 2004; 27: 48.
29. Wang YD, Chen WF. Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2: Ig fusion protein. Clin Immunol 2004; 113: 151.
30. Weng X, Zhong M, Liang Z, et al. Peptide-dependent inhibition of alloreactive T-cell response by soluble divalent HLA-A2/IgG molecule in vitro. Transplantation 2007; 84: 1298.
31. Solheim JC, Harris MR, Kindle CS, et al. Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 1997; 158: 2236.
32. Burlingham WJ, Ceman SS, DeMars R. Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens. Proc Natl Acad Sci USA 1989; 86: 8005.
33. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985; 21: 235.
34. Fang C, Wu X, Gong F. Molecular cloning and sequencing of the cDNA of the soluble human leukocyte antigen-G1. Immunol J 2001; 17: 81.
35. Maziarz RT, Fraser J, Strominger JL, et al. The human HLA-specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the alpha 2 domain of murine H-2Db. Immunogenetics 1986; 24: 206.
36. Xia F, Zhong M, Zhang C, et al. The prokaryotic sHLA-G1 refolded in vitro inhibits T cell proliferation in mixed lymphocytes culture. Chin J Microbiol Immunol 2007; 27: 299.
37. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1,DRB3, DRB4, DRB5 &DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355.
38. Givan AL, Fisher JL, Waugh M, et al. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 1999; 230: 99.
39. Venken K, Thewissen M, Hellings N, et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 2007; 322: 1.
40. Saverino D, Merlo A, Bruno S, et al. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 2002; 168: 207.
41. Shiroishi M, Tsumoto K, Amano K, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003; 100: 8856.
42. Clements CS, Kjer-Nielsen L, Kostenko L, et al. The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: The essential role of cobalt. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006; 62(Pt 1): 70.
43. Baba E, Erskine R, Boyson JE, et al. N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Hum Immunol 2000; 61: 1202.
44. Tormo J, Natarajan K, Margulies DH, et al. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 1999; 402: 623.
45. Borges L, Hsu ML, Fanger N, et al. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 1997; 159: 5192.
46. Cosman D, Fanger N, Borges L. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: More questions than answers. Immunol Rev 1999; 168: 177.
47. LeMaoult J, Zafaranloo K, Le Danff C, et al. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005; 19: 662.
48. Contini P, Ghio M, Poggi A, et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33: 125.
49. Fournel S, Aguerre-Girr M, Huc X, et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100.
50. Sandhu JS, Gorczynski R, Shpitz B, et al. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation 1995; 60: 179.